Targeting ACE2 as a Therapy for COVID-19 Patients

The scientific team at PEARKO Therapeutics is comprised of leading experts in Angiotensin Converting Enzyme 2 (ACE2) biology and function. ACE2 is the receptor for SARS-CoV-2, which is the virus responsible for the COVID-19 pandemic. During this critical time, PEARKO Therapeutics is developing therapies to treat COVID-19 patients by targeting ACE2